Powder Systems Limited (PSL) have signed a licence agreement with Ashe Morris Limited (AML) to develop and supply to market a range of reactors and bioreactors incorporating the patented Constant Flux Technology. Fitting in with the FDA’s PAT (Process Analytical Technology) initiative, Constant Flux Technology has the potential to help reduce drug development times by up to 6 months, getting drugs to market faster.
This new technology uses on-line reaction monitoring (via calorimetry) to provide valuable insight into process specifics to improve yields and end point detection by monitoring the on-line rate of reaction of virtually any chemical, physical or biological process. The range of COFLUX chemical reactors and bio-reactors will be ready for market later this year following the completion of a programme of co-development between PSL and AML.
“This collaboration with AML demonstrates our commitment to providing Total Process Solutions to the drug development and production industry, expanding our portfolio of containment and process capabilities.” said Gary Howse PSL Director.
Powder Systems Ltd.
February 15, 2005
PSL sign licence deal with AML for new
on-line reaction monitoring technology
Powder Systems Limited (PSL) have signed a licence agreement with Ashe Morris Limited (AML) to develop and supply to market a range of reactors and bioreactors incorporating the patented Constant Flux Technology. Fitting in with the FDA’s PAT (Process Analytical Technology) initiative, Constant Flux Technology has the potential to help reduce drug development times by up to 6 months, getting drugs to market faster.
This new technology uses on-line reaction monitoring (via calorimetry) to provide valuable insight into process specifics to improve yields and end point detection by monitoring the on-line rate of reaction of virtually any chemical, physical or biological process. The range of COFLUX chemical reactors and bio-reactors will be ready for market later this year following the completion of a programme of co-development between PSL and AML.
“This collaboration with AML demonstrates our commitment to providing Total Process Solutions to the drug development and production industry, expanding our portfolio of containment and process capabilities.” said Gary Howse PSL Director.
For more information, please visit:
href="https://edir.bulk-online.com/profile/8223-powder-systems.htm" target="blank">https://edir.bulk-online.com/profile...er-systems.htm
Attachments
powdersystems_news_05 (GIF)
■